Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation
AbstractTriple negative breast cancer (TNBC) is an aggressive subtype with limited therapeutic options. New opportunities are emerging from current comprehensive characterization of tumor immune infiltration and fitness. Therefore, effectiveness of current chemotherapies and novel immunotherapies are partially dictated by host inflammatory and immune profiles. However, further progress in breast cancer immuno-oncology is required to reach a detailed awareness of the immune infiltrate landscape and to determine additional reliable and easily detectable biomarkers. In this study, by analyzing gene expression profiles of 54 TNBC cases we identified three TNBC clusters displaying unique immune features. Deep molecular characterization of immune cells cytolytic-activity and tumor-inflammation status reveled variability in the local composition of the immune infiltrate in the TNBC clusters, reconciled by tumor-infiltrating lymphocytes counts. Platelet-to-lymphocyte ratio (PLR), a blood systemic parameter of inflammation evaluated using pre-surgical blood test data, resulted negatively correlated with local tumoral cytolytic activity and T cell–inflamed microenvironment, whereas tumor aggressiveness score signature positively correlated with PLR values. These data highlighted that systemic inflammation parameters may represent reliable and informative markers of the local immune tumor microenvironment in TNBC patients and could be exploited to decipher tumor infiltrate properties and consequently to select the most appropriate therapies. View Full-Text
- Supplementary File 1:
PDF-Document (PDF, 464 KB)
Share & Cite This Article
Romero-Cordoba, S.; Meneghini, E.; Sant, M.; Iorio, M.V.; Sfondrini, L.; Paolini, B.; Agresti, R.; Tagliabue, E.; Bianchi, F. Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation. Cancers 2019, 11, 911.
Romero-Cordoba S, Meneghini E, Sant M, Iorio MV, Sfondrini L, Paolini B, Agresti R, Tagliabue E, Bianchi F. Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation. Cancers. 2019; 11(7):911.Chicago/Turabian Style
Romero-Cordoba, Sandra; Meneghini, Elisabetta; Sant, Milena; Iorio, Marilena V.; Sfondrini, Lucia; Paolini, Biagio; Agresti, Roberto; Tagliabue, Elda; Bianchi, Francesca. 2019. "Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation." Cancers 11, no. 7: 911.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.